Vimarsana
Biggest News Aggregation in the World

Page 33 - Van Herk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Van Herk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Van Herk Today - Breaking & Trending Today

Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger - Vimarsana News

Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger

Chinook Therapeutics Announces Update on Non-Renal Legacy Programs from Aduro Biotech Merger Van Herk Investments to Form and Invest in Sairopa, a New Company Focused on Research and Development of B-Select Monoclonal Antibody Platform Programs VANCOUVER, British Columbia and SEATTLE, April 05, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced a transaction with Van Herk Investments, a leading European life science investor, to ...

BioInvent International Financial Statement January 1 - Vimarsana News

BioInvent International Financial Statement January 1

BioInvent International Financial Statement January 1 - December 31, 2020 LUND, Sweden, Feb. 23, 2021 /PRNewswire/ -- "BioInvent has started 2021 with significant positive momentum We reported promising interim efficacy data from the ongoing Phase I/IIa trial of our lead drug candidate BI-1206.The company also closed a successful SEK 962 million financing round, expanding our institutional shareholder base. Furthermore, we announced the expansion of our clinical pipeline to include two further drug candidates for the treatment of solid tumors." - Martin Welschof, CEO BioInvent Financial info...

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center | Proteins and Peptides - Vimarsana News

Onco-immunology Company Pan Cancer T Launched as Spin-off from Erasmus Medical Center | Proteins and Peptides

Hits: 1900 - Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland ROTTERDAM, The Netherlands I February 8, 2021 I Pan Cancer T B.V., a biotech spin-off from the Erasmus Medical Center founded by Prof. Dr. Reno Debets (CSO) and Dr. Dora Hammerl (VP R&D), announces the closing of a seed investment and start of operations. Together with Katrien Reynders-Frederix (CEO), the team is committed to the discovery and development of novel TCR therapies against solid tumors such as triple negative breast cancer, bladder cancer, lung cancer, and glioma. Seed in...

NSW's Cobar BioHub proposal to turn invasive plants into biomass stalls without investment - Vimarsana News

NSW's Cobar BioHub proposal to turn invasive plants into biomass stalls without investment

NSW's Cobar BioHub proposal to turn invasive plants into biomass stalls without investment WedWednesday 20 JanJanuary 2021 at 5:51am Western Local Land Services say if left untreated, invasive native species choke grassy woodlands and increases susceptibility to erosion. ( Print text only Cancel A bold plan to turn biomass from invasive plant species in western New South Wales into energy is on the cusp of proving it will work on a large scale. Key points: The Cobar BioHub proposes to turn biomass from invasive native species into charcoal, essential oils or specialty timbers Local Land Servi...

Source: abc.net.au
Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered - Vimarsana News

Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered

DAVIS, Calif., Jan. 05, 2021 -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally responsible pest management